Bulimia: A primary care approach

Journal of Women's Health

Volumn 7, Issue 2, 1998, Pages 211-220

  Batal, Holly ^a   Johnson, Marie ^a   Lehman, David ^a   Steele, Andrew ^a   Mehler, Philip S ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; ELECTROLYTE; IPECAC; LAXATIVE;

BODY WEIGHT; BULIMIA; DRUG ABUSE; ELECTROLYTE DISTURBANCE; ESOPHAGUS RUPTURE; FEEDING BEHAVIOR; GASTROINTESTINAL SYMPTOM; GINGIVITIS; HUMAN; HYPOKALEMIA; HYPOVOLEMIA; METABOLIC ALKALOSIS; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SALIVARY GLAND DISEASE; TOOTH DISEASE; VOMITING;

EID: 0031966481     PISSN: 10597115     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.1998.7.211     Document Type: Review

References (52)

1. Russell G. Bulimia nervosa: An ominous variant of anorexia nervosa. Psychol Med 1979;9:429.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV), 4th ed. Washington, DC: Author, 1994.
3. Pryor T. Diagnostic criteria for eating disorders: DSM-IV revisions. Psychiatric Annals 1995;25:40.
4. Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH Jr. Long-term fluoxetine treatment of bulimia nervosa. Br J Psychiatry 1995;166:660.
5. DiNicola VF. Anorexia multi-forme: Self-starvation in historical and cultural context. Transcultural Psychiat Res Rev 1990;27:165.
6. Fairburn CG, Beglin SJ. Studies of the epidemiology of bulimia nervosa. Am J Psychiatry 1990;147:401.
7. Herzog DB, Sacks NR, Keller MB, Lavori PW, von Ranson KB, Gray HM. Patterns and predictors of recovery in anorexia nervosa and bulimia nervosa. J Am Acad Child Adolesc Psychiatry 1973;32:835.
8. Fairburn CG, Norman PA, Welch SL, O'Connor ME. Doll HA, Peveler RC. A prospective study of outcome in bulimia nervosa and the long-term effects of three psychological treatments. Arch Gen Psychiatry 1995;52:304.
9. Herzog DB, Keller MB, Lavori PW, Sacks NR. The course and outcome of bulimia nervosa. J Clin Psychiatry 1991;52(Suppl):4.
10. Fluoxetine Bulimia Nervosa Collaborative Study Group. Fluoxetine in the treatment of bulimia nervosa: A multicenter, placebo-controlled, double blind trial. Arch Gen Psychiatry 1992;49:139.
11. Abrams RA, Ruff SC. Oral signs and symptoms in the diagnosis of bulimia. J Am Dent Assoc 1956;113:761.
12. Altshuler BD, Dechow PC, Waller DA, Hardy BW. An investigation of the oral pathologies occurring in bulimia nervosa. Int J Eating Disorders 1993;14:341.
13. Touyz SW, Liew VP, Tseng P, Frisken K, Williams H, Beumont PJ. Oral and dental complications in dieting disorders. Int J Eat Disord 1993;14:341.
14. Simmons MS, Grayden SK, Mitchell JE. The need for psychiatric-dental liaison in the treatment of bulimia. Am J Psychiatry 1986;143:783.
15. Brewer TL. The necessity for dental awareness of the presenting signs and symptoms of bulimia nervosa. J Okla Dent Assoc 1987;78:24.
16. Milosevic A, Brodie DA, Slade PD. Dental erosion, oral hygiene, and nutrition in eating disorders. Int J Eat Disord 1997;21:195.
17. Mandel L, Kaynar A. Bulimia and parotid swelling: A review and case report. J Oral Maxillofac Surg 1992;50:1122.
18. Kinzl J, Biebl W, Herold M. Significance of vomiting for hyperamylasemia and sialadenosis in patients with eating disorders. Int J Eat Disord 1993;13:117.
19. Philip E, Willershausen-Zonnchen B, Hamm G, Pirke KM. Oral and dental characteristics in bulimic and anorectic patients. Int J Eat Disord 1991;10:423.
20. Spigset O. Oral symptoms in bulimia nervosa. A survey of 34 cases. Acta Odontol Scand 1991;49:335.
21. Gwirstman HE, Kay WH, George DT, Carosella NW, Green RC, Jimerson DC. Hyperamylasemia and its relationship to binge-purge episodes. J Clin Psychiatry 1989;50:196.
22. Mehler PS, Wallace JA. Sialadenosis in bulimia: A new treatment. Arch Otolaryngol Head Neck Surg 1993;119:787.
23. Gwirstman HE, Yager J, Gillard BK. Serum amylase and its isoenzymes in normal weight bulimics. Int J Eat Disord 1986;5:355.
24. Kiss A, Wiesnagrotzki S, Abatzi TA, Meryn S, Haubenstock A, Base W. Upper gastrointestinal endoscopy findings in patients with long-standing bulimia nervosa. Gastrointest Endosc 1989;35:516.
25. Mehler PS, Weiner KL. Frequently asked medical questions about eating disorders. Eat Disord 1994;2:22.
26. Mitchell JE, Seim HC, Colon E, Pomeroy C. Medical complications and medical management of bulimia. Ann Intern Med 1987;107:71.
27. Schechter JO, Altemus M, Greenfeld DG. Food bingeing and esophageal perforation in anorexia nervosa. Hosp Community Psychiatry 1986;37:507.
28. Nickl NJ, Brazer SR, Rockwell K, Smith JW. Patterns of esophageal motility in patients with stable bulimia. Am J Gastroenterol 1996;91:2544.
29. Humphries LL, Shirley PB, Piasick MT. Ipecac misuse in clinical and non-clinical samples. Int J Eat Disord 1992;11:361.
30. Palmer EP, Guay AT. Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N Engl J Med 1985;313:1457.
31. Dresser LP, Massey EW, Johnson EE, Bossen E. Ipecac myopathy and cardiomyopathy. J Neurol Neurosurg Psychiatry 1993;56:560.
32. Neims DM, McNeill J, Giles TR, Todd F. Incidence of laxative abuse in community and bulimic populations: A descriptive review. Int J Eat Disord 1995; 17:211.
33. Bo-Linn GW, Santa Ana CA, Morawski SG, Fordtran JS. Purging and calorie absorption in bulimic patients and normal women. Ann Intern Med 1983;99:14.
34. Muller-Lissner SA. Adverse effects of laxatives: Fact and fiction. Pharmacology 1993;47(Suppl 1):138.
35. Badiali MD, Marcheggiano A, Pallone F, et al. Melanosis of the rectum in patients with chronic constipation. Dis Colon Rectum 1985;28:241.
36. Mehler PS. Constipation: Diagnosis and treatment in eating disorders. Eat Disord 1997;5:41.
37. Bytzer P, Stockhohn M, Andersen I, Klitgaard NA, Schaffalitzky de Muckadell OB. Prevalence of surreptitious laxative abuse in patients with diarrhea of uncertain origin: A cost benefit analysis of a screening procedure. Gut 1989;30:1379.
38. Weltzin TE, Bulik CM, McConaha CW, Kaye WH. Laxative withdrawal and anxiety in bulimia nervosa. Int J Eat Disord 1995;17:141.
39. Berczeller PH. Idiopathic edema. Hosp Pract [Off Ed] 1994;29:115.
40. Bihun JA, McSherry J, Marciano D. Idiopathic edema in eating disorders: Evidence for an association. Int J Eat Disord 1993;14:197.
41. Mitchell JE, Pomeroy C, Huber M. A clinician's guide to the eating disorders' medicine cabinet. Int J Eat Disord 1988;7:211.
42. Greenfeld D, Mickley D, Quinlan DM, Roloff P. Hypokalemia in outpatients with eating disorders. Am J Psychiatry 1995;152:60.
43. Mehler PS. Eating disorders: 2. Bulimia nervosa. Hosp Practice [Off Ed] 1996;31:107.
44. Whang R, Whang DD, Ryan MP. Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med 1992;152:40.
45. C'Connor HT, Richman RM, Steinbeck KS, Caterson ID. Dexfenfluramine treatment of obesity: A double blind trial with post trial follow up. Int J Obes Rel Metab Disord 1995;19:181.
46. National Task Force on the Prevention and Treatment of Obesity. Long-term pharmacotherapy in the management of obesity. JAMA 1996;276:1907.
47. Connolly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997;337:581.
48. Rodin GM, Daneman D. Eating disorders and IDDM: A problematic association. Diabetes Care 1992;15: 1402.
49. Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF. Insulin omission in women with IDDM. Diabetes Care 1994;17:1178.
50. Rydal AC, Rodin GM, Olmsted MP, Devenyi RG, Daneman D. Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus. N Engl J Med 1997;336:1849.
51. Colas C, Mathiew P, Tehobroutsky G. Eating disorders and retinal lesions in type I (insulin dependent) diabetic women. Diabetologia 1991;34:288.
52. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1997;329:977.